Safety and Effectiveness of Piperacillin/Tazobactam (Zosyn®) in the Treatment of Pediatric Hospital Acquired Pneumonia (HAP): A Retrospective Cohort Study

12/01/2015
23/04/2024
EU PAS number:
EUPAS8352
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

Zosyn study B2361001 Protocol_EU PAS Register

English (412.09 KB - PDF) View document
Updated protocol

Zosyn Pediatric HAP Study Protocol Amendment IV (B2361001) __EU PAS

First published: 22/02/2024
English (834.18 KB - PDF) View document
Study results
Study results

B2361001 (Formerly 0910K2-4015) Non-Interventional Study Report Abstract EU PAS Register

English (244.3 KB - PDF) View document
Study report
Study report

B2361001 Full Study Report_EU PAS Register

English (673.67 KB - PDF) View document
Other information